前路腰方肌阻滞用于活体肾移植术后镇痛:双盲随机对照试验
结果显示两组总阿片消耗无显著差异(中位数160.5 vs 187.5口服吗啡毫克当量,中位差-27,95%CI -78至24,p=0.29),次要结局亦无差异。结论不支持该阻滞在此类手术中常规使用。
要点
- 前路腰方肌阻滞未减少活体肾移植术后24小时阿片消耗。
- 两组疼痛评分、首次阿片时间等次要结局均无差异。
- 多模式镇痛背景下不推荐常规行前路腰方肌阻滞。
核心结论
- 前路腰方肌阻滞未减少活体肾移植多模式镇痛患者的阿片消耗,不支持常规使用。
主要发现
- 术后24小时总阿片消耗两组无显著差异(中位数160.5 vs 187.5口服吗啡毫克当量;中位差-27,95%CI -78至24,p=0.29)。
- 次要结局包括疼痛评分、首次阿片时间、感觉阻滞皮节分布、运动无力、恶心呕吐、恢复质量评分、首次下床时间和住院时长均无差异。
关键数值与推荐
- 主要结局:术后24小时总阿片消耗(口服吗啡毫克当量)。
- 干预:单侧前路腰方肌阻滞使用30 mL 0.375%罗哌卡因;对照:生理盐水假阻滞。
- 所有患者接受标准多模式镇痛,包括计划性对乙酰氨基酚和静脉患者自控芬太尼。
临床怎么用
- 在活体肾移植多模式镇痛方案中,不应常规添加前路腰方肌阻滞以期望减少阿片用量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Limited non-opioid analgesic options are available for managing postoperative pain after renal transplantation. We aimed to investigate whether the unilateral anterior quadratus lumborum (QL) block would reduce postoperative opioid consumption after living-donor renal transplantation in the context of multimodal analgesia. METHODS: Eighty-eight adult patients undergoing living-donor renal transplantation were randomly allocated to receive the unilateral anterior QL block (30 mL of ropivacaine 0.375%) or sham block (normal saline) on the operated side before emergence from anesthesia. All patients received standard multimodal analgesia, including the scheduled administration of acetaminophen and fentanyl via intravenous patient-controlled analgesia. The primary outcome was the total opioid consumption during the first 24 hours after transplantation. The secondary outcomes included pain scores, time to first opioid administration, cutaneous distribution of sensory blockade, motor weakness, nausea/vomiting, quality of recovery scores, time to first ambulation, and length of hospital stay. RESULTS: The total opioid consumption in the first 24 hours after transplantation did not differ significantly between the intervention and control groups (median (IQR), 160.5 (78-249.8) vs 187.5 (93-309) oral morphine milligram equivalent; median difference (95% CI), -27 (-78 to 24), p=0.29). No differences were observed in the secondary outcomes. CONCLUSIONS: The anterior QL block did not reduce opioid consumption in patients receiving multimodal analgesia after living-donor renal transplantation. Our findings do not support the routine administration of the anterior QL block in this surgical population. TRIAL REGISTRATION NUMBER: NCT04908761.
引用
- Kim Y, Kim JT, Yang SM, et al. Anterior quadratus lumborum block for analgesia after living-donor renal transplantation: a double-blinded randomized controlled trial. Reg Anesth Pain Med. 2024. PMID: 37704438. doi:10.1136/rapm-2023-104788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。